2nd Gene Therapy Potency Assay Summit 2024

Navigate Matrix Approaches for Potency, Elucidate Mechanism of Action for Complex Gene Therapies and Consistently Measure Biological Activity to Demonstrate Product Efficacy to Regulators

Time: 9:00 AM – 5:30 PM

Venue Details: The Colonnade Hotel, 120 Huntington Avenue, Boston, Massachusetts, 02116, United States

Prices:
Conference + 2 Workshops – Drug Developers: USD 4397.00,
Conference + 2 Workshops – Service Providers: USD 2999.00,
Conference Only – Drug Developers: USD 5297.00,
Conference Only – Service Providers: USD 3699.00

Speakers: Adnan Arnaout Senior Principal Scientist, Prevail Therapeutics, Alec Knapp Scientist, Tune Therapeutics, David Schwalb, Director – Analytical Development, Cell and Gene Therapies, Pacira Biosciences, Geeta Iyer, PD Manager, Assay Development, Beacon Therapeutics, Georgios Tsouchnikas, Head Of Assay Development, Hookipa Pharma Inc., Gillian Payne, Vice President – Analytical Development, Carbon Biosciences, Haiqing Yu, Senior Scientist and Analytical Team Manager, Sanofi, Hangtian Song, Associate Scientific Director, Bristol Myers Squibb, Hesham Nawar, Director – Analytical Development, Spark Therapeutics, and more